electroCore, LLC is a U.S.-based neuroscience and technology company dedicated to improving patient outcomes through technological advancement and focused on developing non-invasive vagus nerve stimulation therapy for the treatment of multiple conditions in neurology, inflammation, and metabolic syndrome. The company's initial target is the treatment of primary headache (migraine and cluster headache) and the associated chronic co-morbidities of gastric motility, psychiatric, sleep, and pain disorders that drive disproportionately large direct and indirect costs within the healthcare system and society.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/29/17 | $70,000,000 | Series B |
American Investment Holdings Core Ventures Group Gakasa Merck Global Health Innovation Fund Vinik Family Foundation | undisclosed |
